With industry waiting on the FDA to issue regs for CBD products, the agency instead released a statement explaining why it has not yet done so—including fears that the trendy cannabinoid may cause liver damage. But advocates charge that the claim is based on faulty research.
Recent comments
9 weeks 4 days ago
13 weeks 5 days ago
15 weeks 2 days ago
15 weeks 3 days ago
27 weeks 5 days ago
33 weeks 3 days ago
44 weeks 3 days ago
45 weeks 2 days ago
46 weeks 6 days ago
47 weeks 3 days ago